Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Internet Of Medical Things (IOMT) For Drug Delivery Market Size Forecast: How Big Could The Market Get By 2030?
The internet of medical things (iomt) for drug delivery market has experienced substantial growth in its size over recent years. This market is projected to expand from $6.57 billion in 2025 to $7.14 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.8%. Historically, this expansion has been driven by the increasing prevalence of chronic diseases, the early adoption of smart infusion and monitoring devices, the growth of home healthcare services, a rising focus on medication adherence, and the expansion of digital health infrastructure.
The internet of medical things (iomt) for drug delivery market is projected to experience substantial expansion over the coming years. This market is predicted to reach a valuation of $10.09 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.0%. Factors contributing to this growth during the forecast period include the broadening of personalized medicine applications, increasing investments in connected healthcare platforms, an escalating demand for remote patient management solutions, the expanding integration of AI-driven dosing algorithms, and growing regulatory encouragement for digital therapeutics. Key trends anticipated within the forecast period encompass a greater uptake of connected drug delivery devices, the increasing deployment of real-time patient monitoring platforms, the evolving integration of wearable and implantable delivery systems, the development of personalized dosage management solutions, and a heightened emphasis on remote therapy management.
Get A Free Sample Report With In-Depth Market Insights:
Internet Of Medical Things (IOMT) For Drug Delivery Market Demand Drivers Opening New Revenue Streams
The increasing prevalence of telehealth and remote care services is anticipated to fuel the expansion of the internet of medical things (IoMT) for drug delivery market in the coming period. These services involve providing healthcare via digital platforms, allowing individuals to access medical advice, oversight, and therapy from home, thereby eliminating the need for physical appointments. The surge in telehealth and remote care can be attributed to a growing patient preference for accessible, convenient healthcare that enables at-home consultations, health monitoring, and treatment management, reducing the necessity of frequent hospital visits. The internet of medical things (IoMT) for drug delivery facilitates telehealth and remote care by offering capabilities such as continuous monitoring of patient adherence to medication, automated and accurate drug dispensing, and effortless data exchange with medical professionals. This empowers doctors to remotely oversee treatment advancement, modify dosages, and deliver individualized care, all without the need for physical encounters. An illustrative example is seen in April 2023, where FAIR Health Inc., a US-based non-profit organization, reported a 7.3% increase in national telehealth utilization, escalating from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Consequently, the expanding embrace of telemedicine platforms is propelling the growth of the internet of medical things (IoMT) for drug delivery market.
Internet Of Medical Things (IOMT) For Drug Delivery Market Segment Trends And Revenue Contributors
The internet of medical things (iomt) for drug delivery market covered in this report is segmented –
1) By Type: Wearable Drug Delivery Devices; Smart Inhalers; Injectable Drug Delivery Systems; Implantable Drug Delivery Devices; Remote Drug Monitoring
2) By Connectivity: Bluetooth And Low Energy Connectivity; Wi Fi Connectivity; Cellular Connectivity; Near Field Communication; Cloud And Edge Based Connectivity
3) By Application: Chronic Disease Management; Acute Care Drug Delivery; Home Based Drug Administration; Hospital And Clinical Drug Delivery; Personalized And Precision Medicine
4) By End User: Hospitals And Clinics; Home Care Settings; Pharmaceutical And Biotechnology Companies; Research And Development Organizations; Contract Research And Clinical Trial Centers
Subsegments:
1) By Wearable Drug Delivery Devices: On Body Infusion Pumps; Patch Based Drug Delivery Systems; Wearable Insulin Delivery Devices; Wearable Pain Management Devices
2) By Smart Inhalers: Connected Metered Dose Inhalers; Connected Dry Powder Inhalers; Medication Adherence Monitoring Inhalers; Dose Tracking Inhaler Systems
3) By Injectable Drug Delivery Systems: Connected Auto Injectors; Smart Pen Injectors; Pre Filled Smart Syringes; Electronic Injection Monitoring Systems
4) By Implantable Drug Delivery Devices: Implantable Infusion Pumps; Controlled Release Implant Systems; Programmable Drug Delivery Implants; Long Term Therapeutic Implants
5) By Remote Drug Monitoring: Medication Adherence Monitoring Systems; Real Time Dosage Tracking Platforms; Remote Therapy Management Systems; Patient Compliance Monitoring Solutions
Internet Of Medical Things (IOMT) For Drug Delivery Market Trends Powering Strategic Industry Growth
Major companies operating in the internet of medical things (IoMT) for drug delivery market are concentrating on developing advanced solutions such as connected smart drug-delivery devices with real-time monitoring. These innovations aim to enable personalized dosing, improve treatment adherence, and enhance patient outcomes. Connected smart drug-delivery devices with real-time monitoring are medical instruments that automatically record medication delivery and patient data, sharing it wirelessly with applications or healthcare systems. This functionality helps optimize dosing, improve adherence, and facilitate timely clinical decisions. For instance, in November 2024, Medtronic plc, an Ireland-based healthcare technology company, introduced its Smart MDI system, featuring the InPen app with Simplera CGM. This system integrates a smart insulin pen with a disposable, all-in-one CGM to provide real-time, personalized insulin dosing insights, including recommendations for detecting and correcting missed or inaccurate mealtime doses. It continuously monitors glucose levels, logs insulin administration, and analyzes patient data via a mobile application to mitigate hyperglycemia risk and support improved glycemic control. Compared to conventional insulin pens, this solution offers automated data capture, intelligent alerts, and clinical decision support, substantially reducing dosing guesswork and improving patient outcomes.
Internet Of Medical Things (IOMT) For Drug Delivery Market Leading Companies And Competitive Benchmarking
Major companies operating in the internet of medical things (iomt) for drug delivery market are Siemens AG, F. Hoffmann-La Roche AG, IBM Corporation, Bayer AG, Oracle Corporation, Abbott Laboratories, Honeywell Life Care Solutions Inc., Medtronic plc, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Becton Dickinson and Company, Cognizant Technology Solutions Corporation, Biogen Inc., Omron Healthcare Co. Ltd., Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Senseonics Inc., AdhereTech Inc., Adherium Limited
View The Full Internet Of Medical Things (IOMT) For Drug Delivery Market Report:
Internet Of Medical Things (IOMT) For Drug Delivery Market Top Region By Revenue And Market Share
North America was the largest region in the internet of medical things (IOMT) for drug delivery market in 2025. The regions covered in the internet of medical things (iomt) for drug delivery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
